Pharmesis International Ltd. provided earnings guidance for the second half and financial year ended 31 December 2021. The Group expected to report a net profit for the unaudited financial results for the second half and financial year ended 31 December 2021 as compared to a net loss for the corresponding periods for the second half and financial year ended 31 December 2020. The expected net profit was mainly attributed to higher other income and lower costs in the second half and financial year ended 31 December 2021.